OTC · CFOR
CapForce Inc.
$9.00$0.00 (0.0%)
CapForce Inc.’s quoted price sits in the lower half of its reported 52-week range, 73.53% below the high.
Loading market information…
NASDAQ · NUVO · USD
Stock price
Quote as of Feb 10, 2026, 09:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Holdco Nuvo Group D.G Ltd. Ordinary Shares’s quoted price sits in the lower half of its reported 52-week range, 22.73% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Holdco Nuvo Group D.G Ltd specializes in the innovation, development, and commercialization of medical devices designed for monitoring pregnancies. Its operations span Israel, the United States, and international markets. The company's key offering is the INVU platform, a remote pregnancy monitoring system that provides expectant mothers with a wearable, self-applied wireless sensor. This technology empowers both the mothers and their obstetricians to track maternal and fetal heart rates, along with maternal uterine activity, conveniently from the comfort of home or within a clinical setting, starting from the 32nd week of gestation until the commencement of labor. The INVU platform itself comprises two main elements: a sophisticated wireless sensor band that utilizes multi-modality technology to capture essential physiological signals, and a complementary cloud-based computing environment. This cloud system is responsible for processing and analyzing the collected data, subsequently generating and delivering customized reports on maternal and fetal health metrics. These insights are then conveyed to the mother and her obstetrician through intuitive digital visualization tools. The company has established strategic partnerships with Royal Philips and Charité – Universitätsmedizin Berlin. Founded in 2006, the firm maintains its headquarters in Tel Aviv, Israel, and was formerly known as Nuvo Group Ltd. before changing its name to Holdco Nuvo Group D.G Ltd in May 2024. Notably, on August 22, 2024, Holdco Nuvo Group D.G Ltd initiated Chapter 11 reorganization proceedings by filing a voluntary petition with the U.S. Bankruptcy Court for the District of Delaware.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:52 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$9.00$0.00 (0.0%)
CapForce Inc.’s quoted price sits in the lower half of its reported 52-week range, 73.53% below the high.
$0.81-$0.03 (-3.13%)
Elutia Inc’s quoted price sits in the lower half of its reported 52-week range, 41.47% below the high.
$0.07+$0.01 (+11.29%)
Osceola Gold, Inc.’s quoted price sits in the lower half of its reported 52-week range, 56.88% below the high.
SEK 0.17-SEK 0.01 (-4.77%)
Acarix AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 50.19% below the high.
$0.62+$0.02 (+2.48%)
Genenta Science S.p.A.’s quoted price sits in the lower half of its reported 52-week range, 80.32% below the high.
$0.73-$0.08 (-10.09%)
Ainos, Inc.’s quoted price sits in the lower half of its reported 52-week range, 81.21% below the high.
$1.03$0.00 (0.0%)
ENvue Medical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 82.78% below the high.
$0.54-$0.03 (-5.08%)
Bluejay Diagnostics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 94.1% below the high.
